Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 15, 2023
Abstract
A
series
of
8-(piperazin-1-yl)imidazo[
1,2-a
]pyrazine
derivatives
were
designed
and
synthesized
as
acetylcholinesterase
inhibitors
(AChEIs)
antioxidants
for
the
treatment
Alzheimer's
disease
(AD).
Moreover,
biological
evaluation
results
demonstrated
that
these
compounds
exhibited
moderate
inhibitory
activities
toward
(AChE)
radical
scavenging
activities.
Among
them,
23l
was
most
potent
AChE
inhibitor
with
an
IC
50
value
0.55
µM,
which
higherthe
5.01
galantamine
reference
compound;
while
23g
had
best
antioxidant
activity
36.28
lower
than
ascorbic
acid
control
drug.
Furthermore,
molecular
docking
studies
indicate
can
simultaneously
bind
to
both
catalytic
active
site
(CAS)
peripheral
anionic
(PAS)
AChE,
consistent
mixed
inhibition
pattern
shown
by
enzyme
kinetic
studies.
The
interaction’s
stability
23l-AChE/BChE
also
assessed
using
a
conventional
atomistic
100
ns
dynamics
simulation
study,
revealed
conformational
representative
compound
in
cavity
AChE.
In
addition,
properties
all
predicted
online
through
molinspiration
server,
matched
orally
administered
drugs.
Based
on
properties,
AChEIs
is
valuable
further
development.
Antioxidants,
Год журнала:
2024,
Номер
13(2), С. 203 - 203
Опубликована: Фев. 5, 2024
Antioxidant
peptides
are
currently
a
hotspot
in
food
science,
pharmaceuticals,
and
cosmetics.
In
different
fields,
the
screening,
activity
evaluation,
mechanisms,
applications
of
antioxidant
pivotal
areas
research.
Among
these
topics,
efficient
screening
stands
at
forefront
cutting-edge
To
this
end,
with
novel
technologies
has
significantly
accelerated
research
process,
gradually
replacing
traditional
approach.
After
screened
identified,
time-consuming
evaluation
is
another
indispensable
procedure,
especially
vivo
models.
Cellular
rodent
models
have
been
widely
used
for
whilst
non-rodent
provide
an
solution,
even
potential
high-throughput
screening.
Meanwhile,
further
molecular
mechanisms
can
elucidate
essence
underlying
activity,
which
related
to
several
signaling
pathways,
including
Keap1-Nrf2/ARE,
mitochondria-dependent
apoptosis,
TGF-β/SMAD,
AMPK/SIRT1/PGC-1α,
PI3K/Akt/mTOR,
NF-κB.
Last
but
not
least,
broad
manufacture,
therapy,
cosmetics
industry,
requires
systematic
review.
This
review
introduces
peptides,
categorized
new
vision.
A
wide
range
assays,
encompassing
cellular
models,
as
well
provided
comprehensive
manner.
addition,
recent
advances
analyzed
specific
cases.
Finally,
production,
systematically
reviewed.
ACS Chemical Neuroscience,
Год журнала:
2024,
Номер
15(9), С. 1828 - 1881
Опубликована: Апрель 22, 2024
Neurodegenerative
diseases
(NDs)
are
one
of
the
prominent
health
challenges
facing
contemporary
society,
and
many
efforts
have
been
made
to
overcome
(or)
control
it.
In
this
research
paper,
we
described
a
practical
one-pot
two-step
three-component
reaction
between
3,4-dihydronaphthalen-1(2H)-one
(1),
aryl(or
heteroaryl)glyoxal
monohydrates
(2a–h),
hydrazine
monohydrate
(NH2NH2•H2O)
for
regioselective
preparation
some
3-aryl(or
heteroaryl)-5,6-dihydrobenzo[h]cinnoline
derivatives
(3a–h).
After
synthesis
characterization
mentioned
cinnolines
(3a–h),
in
silico
multi-targeting
inhibitory
properties
these
heterocyclic
scaffolds
investigated
upon
various
Homo
sapiens-type
enzymes,
including
hMAO-A,
hMAO-B,
hAChE,
hBChE,
hBACE-1,
hBACE-2,
hNQO-1,
hNQO-2,
hnNOS,
hiNOS,
hPARP-1,
hPARP-2,
hLRRK-2(G2019S),
hGSK-3β,
hp38α
MAPK,
hJNK-3,
hOGA,
hNMDA
receptor,
hnSMase-2,
hIDO-1,
hCOMT,
hLIMK-1,
hLIMK-2,
hRIPK-1,
hUCH-L1,
hPARK-7,
hDHODH,
which
confirmed
their
functions
roles
neurodegenerative
(NDs),
based
on
molecular
docking
studies,
obtained
results
were
compared
with
wide
range
approved
drugs
well-known
(with
IC50,
EC50,
etc.)
compounds.
addition,
ADMET
prediction
analysis
was
performed
examine
prospective
drug
synthesized
compounds
The
from
studies
ADMET-related
data
demonstrated
that
series
heteroaryl)-5,6-dihydrobenzo[h]cinnolines
especially
hit
ones,
can
really
be
turned
into
potent
core
new
treatment
and/or
due
having
reactionable
locations,
they
able
further
organic
reactions
(such
as
cross-coupling
reactions),
expansion
(for
example,
using
other
types
monohydrates)
makes
avenue
designing
novel
efficient
purpose.
ACS Omega,
Год журнала:
2024,
Номер
9(47), С. 46860 - 46878
Опубликована: Ноя. 16, 2024
The
new
dibenzoazepine-substituted
triazole
hybrids
(12–20)
were
designed
by
molecular
hybridization
approach
and
synthesized
utilizing
the
Cu(I)-catalyzed
click
reaction.
hybrid
structures
obtained
in
high
yields
(74–98%)
with
a
simple
two-step
synthesis
strategy
fully
characterized.
These
compounds
assessed
for
their
influence
on
various
metabolic
enzymes
including
human
carbonic
anhydrase
isoenzymes
(hCA
I
hCA
II),
acetylcholinesterase
(AChE),
butyrylcholinesterase
(BChE).
Ki
values
concerning
I,
II,
AChE,
BChE
ranges
29.94–121.69,
17.72–89.42,
14.09–44.68,
1.15–48.82
nM,
respectively.
Compound
13
was
49.70-fold
more
active
than
tacrine
(standard
drug)
5.49-fold
AChE.
14
4.16-fold
acetazolamide
5.79-fold
II.
cytotoxic
effects
of
products
investigated
triple-negative
breast
cancer
cell
lines.
IC50
most
effective
calculated
between
12.51
±
1.92
18.07
2.14
μM
MDA-MB-231
BT-549
cells.
Molecular
docking
ADME
predictions
performed.
Then,
vitro
analyzed
dynamics
(MD)
simulation
MM/GBSA
calculation.
Consequently,
showed
good
cytotoxicity
inhibition
potential
colony
formation
Oriental Journal Of Chemistry,
Год журнала:
2025,
Номер
40(6), С. 1696 - 1702
Опубликована: Янв. 3, 2025
The
successful
treatment
strategy
for
Alzheimer's
disease
focuses
on
inhibiting
acetylcholinesterase
(AChE)
and
butyrylcholinesterase
(BChE)
to
enhance
cholinergic
activity.
This
study
aimed
design
fifteen
9H-(fluorenyl)methyl
lysine
carbamate
derivatives
(4a-o)
as
potential
BChE
inhibitors
perform
molecular
docking
studies
identify
their
binding
sites
evaluate
mechanisms
the
protein
by
Glide
software.
results
revealed
that
most
potent
compounds
were
4a,
4c,
4j,
with
scores
of
-10.53,
-10.57,
-10.85
kcal/mol,
respectively
indicating
strong
affinities
enzyme,
suggesting
inhibitors.
Notably,
compound
4j
exhibited
complete
oral
absorption,
high
permeability
in
MDCK
cells,
good
skin
permeability.
Its
surface
area
components
within
acceptable
ranges.
Thus,
is
proposed
a
promising
candidate
experimental
evaluation
inhibitor.
Journal of Biomolecular Structure and Dynamics,
Год журнала:
2025,
Номер
unknown, С. 1 - 15
Опубликована: Янв. 28, 2025
Alzheimer's
disease
is
one
of
the
most
complex
neurological
disorders
and
millions
people
are
suffering
from
this
all
over
world.
In
past
two
decades
acetylcholinesterase
(AChE)
has
been
explored
pathological
hallmark.
The
generation
potent
AChE
inhibitors
grown
as
a
rapid
tool
for
efficacious
treatment
disease.
Hence,
enzyme
extensively
drug
discovery
development
therapeutics.
We
have
used
chromone
derivatives
with
known
biological
activities
developing
Gaussian
field-based
3D
QSAR
pharmacophore
model
using
PHASE
module
Schrodinger
statistically
significant
R2
Q2
values
0.92
0.9209,
respectively.
ChEMBL
MCULE
databases
were
screened
best
hypothesis
(AAHHRR_4)
features
hydrogen
bond
acceptors
(A1,
A2),
hydrophobic
regions
(H1,
H2),
aromatic
(R1,
R2).
These
subjected
to
structure-based
virtual
screening
extra
precision,
MM/GBSA
ADME
calculations
calculating
binding
free
energies
pharmacokinetic
properties,
Subsequently,
hit
molecules
i.e.
CHEMBL1319989
MCULE-2246633290
identified.
leads
exhibited
higher
docking
score
(-8.859
-9.984
kcal/mol)
ΔGbinding
(-57.63
-56.45
compared
reference
(ΔGbinding=
-53.79
kcal/mol).
MD
simulation
study
stable
interactions
energy
(ΔGMMPBSA)
-27.29
-21.26
kcal/mol
MCULE-2246633290,
So,
generated
may
be
considered
valuable
AD.
RSC Medicinal Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Donepezil-based
rational
design
of
N
-substituted
quinazoline
tethered
thioacetamide
as
potential
acetylcholine
esterase
inhibitors
for
the
treatment
Alzheimer's
disease.